Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NGM Biopharmaceuticals, Inc. - Common Stock (NQ:NGM)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NGM Biopharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday
Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million... 
Via Benzinga
US Stocks Turn Lower; Dow Tumbles Over 100 Points
U.S. stocks turned lower toward the end of trading, with the Dow Jones dropping more than 100 points on Thursday. 
Via Benzinga
Where NGM Biopharmaceuticals Stands With Analysts
Within the last quarter, NGM Biopharmaceuticals (NASDAQ:NGM) has observed the following analyst ratings: 
Via Benzinga
4 Analysts Have This to Say About NGM Biopharmaceuticals
Within the last quarter, NGM Biopharmaceuticals (NASDAQ:NGM) has observed the following analyst ratings: 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers 
Via Benzinga
Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session
Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares jumped 126% to $0.4525 after the company announced its NextFintech division received commitment for a $15 million strategic investment. 
Via Benzinga
Analyst Ratings for NGM Biopharmaceuticals
NGM Biopharmaceuticals (NASDAQ:NGM) has observed the following analyst ratings within the last quarter: 
Via Benzinga
NGM Bio Plunges As Experimental Drug Fails To Meet Primary Goal In Age-Related Vision Loss Disorder
 
Via Benzinga
NGM Bio Presents Preliminary Data From NGM120 Combo Trial In Pancreatic Cancer
 
Via Benzinga
Nasdaq Rises Over 100 Points; Crude Oil Up 1.5%
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday. 
Via Benzinga
Short Volatility Alert: NGM Biopharmaceuticals, Inc.
On Wednesday, shares of NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) experienced volatile short activity. After the activity, the stock price went down -0.81% to $3.69. The overall sentiment for NGM has... 
Via Benzinga
$1.9 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones dropped by around 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
Dow Rises Over 2%; S&P 500 Up 100 Points
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 300 points on Monday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers 
Via Benzinga
NGM Bio To Highlight Updated Preliminary Findings From Advanced Solid Tumors Trial
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
Upgrades 
Via Benzinga
Dow Looks To Reclaim Friday Losses As Stocks Rise
Stocks are starting the week strong, extending this morning's gains at midday. 
Via Talk Markets
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case. 
Via Benzinga
Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday's Mid-Day Session
Gainers FedNat Holding Company (NASDAQ: FNHC) shares rose 78.9% to $0.93 after jumping 48% on Friday. 
Via Benzinga
How Is The Market Feeling About NGM Biopharmaceuticals?
NGM Biopharmaceuticals's (NASDAQ:NGM) short percent of float has risen 23.05% since its last report. The company recently reported that it has 2.67 million shares sold short, which is 12.28% of all... 
Via Benzinga
Nasdaq Jumps 300 Points; Bank of America Tops Q3 Estimates
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 300 points on Monday. 
Via Benzinga
NGM Biopharmaceuticals, Fox Corporation And Some Other Big Stocks Moving Lower On Monday
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
US Stocks Open Higher; Dow Surges 500 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining around 500 points on Monday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Acorda Therapeutics (NASDAQ:ACOR) shares increased by 46.1% to $0.49 during Monday's pre-market session. The company's market cap stands at $11.9 million. 
Via Benzinga
NGM Bio Announces Topline Results from the CATALINA Phase 2 Trial of NGM621 in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
From NGM Biopharmaceuticals, Inc.
Via GlobeNewswire
NGM Bio to Host Conference Call to Discuss Topline Results from the CATALINA Phase 2 Trial of NGM621 in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration
From NGM Biopharmaceuticals, Inc.
Via GlobeNewswire
Poshmark, Rivian Automotive And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning after recording gains in the previous session. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Why AeroClean Technologies Is Trading Higher By Over 39%; Here Are 26 Stocks Moving Premarket
Gainers Bit Brother Limited (NASDAQ: BTB) rose 91.7% to $0.2150 in pre-market trading after declining around 14% on Monday. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
NGM Biopharmaceuticals's Return On Capital Employed Insights
Benzinga Pro data, NGM Biopharmaceuticals (NASDAQ:NGM) reported Q2 sales of $8.29 million. Earnings fell to a loss of $46.52 million, resulting in a 43.36% decrease from last quarter. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.